{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:49:17Z","timestamp":1787064557641,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014264","name":"Association Fran\u00e7ois Aupetit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014674","name":"Conseil Regional Grand Est","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.biopha.2021.112543","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T09:27:58Z","timestamp":1639992478000},"page":"112543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mesalazine initiates an anti-oncogenic \u03b2-catenin \/ MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms"],"prefix":"10.1016","volume":"146","author":[{"given":"Emilie","family":"Bersuder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Terciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Lechevrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Quesnelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Noel","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Reimund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Collaborators GBDIBD","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.112543_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.biopha.2021.112543_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5126048","article-title":"The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer","volume":"2017","author":"Luo","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2021.112543_bib4","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1016\/S0399-8320(09)73154-9","article-title":"Colon cancer in inflammatory bowel disease: recent trends, questions and answers","volume":"33","author":"Viennot","year":"2009","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112543_bib5","first-page":"2727","article-title":"Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies","volume":"29","author":"Triantafillidis","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2021.112543_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jcm9051273","article-title":"Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products","volume":"9","author":"Yeshi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"10080","key":"10.1016\/j.biopha.2021.112543_bib7","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations","volume":"7","author":"Van Assche","year":"2013","journal-title":"J. Crohns Colitis"},{"issue":"9","key":"10.1016\/j.biopha.2021.112543_bib9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/apt.14023","article-title":"Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"45","author":"Bonovas","year":"2017","journal-title":"Aliment Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2021.112543_bib10","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1158\/0008-5472.CAN-04-3824","article-title":"Mesalazine improves replication fidelity in cultured colorectal cells","volume":"65","author":"Gasche","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/carcin\/24.3.443","article-title":"Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells","volume":"24","author":"Reinacher-Schick","year":"2003","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2000-135","article-title":"Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel","volume":"32","author":"Reinacher-Schick","year":"2000","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib13","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1038\/s41598-019-39401-0","article-title":"Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation","volume":"9","author":"Khare","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112543_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2013.10.021","article-title":"Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells","volume":"87","author":"Khare","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2036.2009.04149.x","article-title":"Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells","volume":"31","author":"Parenti","year":"2010","journal-title":"Aliment Pharmacol. Ther."},{"issue":"32","key":"10.1016\/j.biopha.2021.112543_bib16","doi-asserted-by":"crossref","first-page":"24622","DOI":"10.1074\/jbc.M000234200","article-title":"mu-Protocadherin, a novel developmentally regulated protocadherin with mucin-like domains","volume":"275","author":"Goldberg","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112543_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yexcr.2017.03.001","article-title":"Evolution and diversity of cadherins and catenins","volume":"358","author":"Gul","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112543_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2014.01.067","article-title":"Intestinal brush border assembly driven by protocadherin-based intermicrovillar adhesion","volume":"157","author":"Crawley","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib19","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.00012.2002","article-title":"Identification and expression analysis of the human mu-protocadherin gene in fetal and adult kidneys","volume":"283","author":"Goldberg","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112543_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1203\/01.PDR.0000125260.46861.32","article-title":"Expression of a novel cadherin in the mouse and human intestine","volume":"55","author":"Moulton","year":"2004","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.gastro.2018.05.028","article-title":"Abnormal small intestinal epithelial microvilli in patients with Crohn\u2019s disease","volume":"155","author":"VanDussen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112543_bib22","article-title":"Epigenetic-mediated downregulation of Mu-protocadherin in colorectal tumours","volume":"2015","author":"Bujko","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"7","key":"10.1016\/j.biopha.2021.112543_bib23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.humpath.2010.10.009","article-title":"Down-regulation of mu-protocadherin expression is a common event in colorectal carcinogenesis","volume":"42","author":"Losi","year":"2011","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41388-020-01546-y","article-title":"The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms","volume":"40","author":"Beck","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2021.112543_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2011.12.037","article-title":"Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and beta-catenin activity in colon cancer cells","volume":"142","author":"Hinkel","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112543_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diff.2019.01.002","article-title":"Wnt signaling in intestinal inflammation","volume":"108","author":"Moparthi","year":"2019","journal-title":"Differentiation"},{"issue":"5307","key":"10.1016\/j.biopha.2021.112543_bib27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma","volume":"275","author":"Korinek","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112543_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2016.10.040","article-title":"The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton","volume":"386","author":"Platet","year":"2017","journal-title":"Cancer Lett."},{"issue":"50","key":"10.1016\/j.biopha.2021.112543_bib29","doi-asserted-by":"crossref","first-page":"43013","DOI":"10.1074\/jbc.M111.261271","article-title":"Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons","volume":"286","author":"Benosman","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112543_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.163","article-title":"Expression of mu-protocadherin is negatively regulated by the activation of the beta-catenin signaling pathway in normal and cancer colorectal enterocytes","volume":"7","author":"Montorsi","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.112543_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.35","article-title":"Epigenetic and genetic features of 24 colon cancer cell lines","volume":"2","author":"Ahmed","year":"2013","journal-title":"Oncogenesis"},{"issue":"6","key":"10.1016\/j.biopha.2021.112543_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2021.112543_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2021.112543_bib34","first-page":"5","article-title":"Tumor heterogeneity in primary colorectal cancer and corresponding metastases. does the apple fall far from the tree?","author":"Blank","year":"2018","journal-title":"Front. Med."},{"issue":"6625","key":"10.1016\/j.biopha.2021.112543_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/386623a0","article-title":"Genetic instability in colorectal cancers","volume":"386","author":"Lengauer","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112543_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/620839","article-title":"PPARgamma in inflammatory bowel disease","volume":"2012","author":"Annese","year":"2012","journal-title":"PPAR Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbadis.2010.11.008","article-title":"The role of CDX2 in intestinal homeostasis and inflammation","volume":"1812","author":"Coskun","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2021.112543_bib38","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3748\/wjg.v21.i5.1436","article-title":"Extending the functions of the homeotic transcription factor Cdx2 in the digestive system through nontranscriptional activities","volume":"21","author":"Freund","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"19","key":"10.1016\/j.biopha.2021.112543_bib39","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1158\/0008-5472.CAN-12-1806","article-title":"Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors","volume":"72","author":"Shenoy","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2021.112543_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/102737","article-title":"The role of PPARs in cancer","volume":"2008","author":"Tachibana","year":"2008","journal-title":"PPAR Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.112543_bib41","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/carcin\/bgl071","article-title":"Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt\/beta-catenin pathway activity","volume":"27","author":"Bos","year":"2006","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2021.112543_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.gastro.2009.10.038","article-title":"Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis","volume":"138","author":"Brown","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112543_bib43","first-page":"B4820","article-title":"The role of CDX2 in inflammatory bowel disease","volume":"61","author":"Coskun","year":"2014","journal-title":"Dan. Med J."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.112543_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)02650-9","article-title":"Stimulation of Cdx1 by oncogenic beta-catenin\/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein","volume":"518","author":"Domon-Dell","year":"2002","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.biopha.2021.112543_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/carcin\/bgp213","article-title":"The intestine-specific transcription factor Cdx2 inhibits beta-catenin\/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex","volume":"31","author":"Guo","year":"2010","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40169-017-0144-7","article-title":"Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT\/beta-catenin pathway","volume":"6","author":"Lecarpentier","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2021.112543_bib47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fimmu.2013.00280","article-title":"Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics","volume":"4","author":"Pastorelli","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.biopha.2021.112543_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2012.10.026","article-title":"Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1","volume":"85","author":"Khare","year":"2013","journal-title":"Biochem Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112543_bib50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/carcin\/23.7.1139","article-title":"Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation","volume":"23","author":"Okazaki","year":"2002","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1091\/mbc.E18-09-0558","article-title":"Brush border protocadherin CDHR2 promotes the elongation and maximized packing of microvilli in vivo","volume":"30","author":"Pinette","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2021.112543_bib52","doi-asserted-by":"crossref","DOI":"10.2174\/0929867328666210219142737","article-title":"The link between bacterial inflammagens, leaky gut syndrome and colorectal cancer","author":"de Waal","year":"2021","journal-title":"Curr. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-018-0483-8","article-title":"Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis","volume":"25","author":"Yu","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112543_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molonc.2008.10.005","article-title":"PCDH24-induced contact inhibition involves downregulation of beta-catenin signaling","volume":"3","author":"Ose","year":"2009","journal-title":"Mol. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221013305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:42:55Z","timestamp":1779964975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221013305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":54,"alternative-id":["S0753332221013305"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112543","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesalazine initiates an anti-oncogenic \u03b2-catenin \/ MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112543"}}